Your browser doesn't support javascript.
loading
The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report.
Hardenberg, M C; Patel, B; Matthews, C; Califano, R; Garcia Campelo, R; Grohe, C; Hong, M H; Liu, G; Lu, S; de Marinis, F; Pérol, M; Soo, R A; Stiles, B M; Tiseo, M; Tsuboi, M.
Afiliação
  • Hardenberg MC; Charles River Associates, Cambridge, UK. Electronic address: mhardenberg@crai.com.
  • Patel B; Charles River Associates, Cambridge, UK.
  • Matthews C; Charles River Associates, Cambridge, UK.
  • Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, UK.
  • Garcia Campelo R; Coruña University Hospital, Medical Oncology Unit, Coruña, Spain.
  • Grohe C; Department of Respiratory Diseases, ELK Thorax Center, Berlin, Germany.
  • Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Liu G; University of Toronto, Princess Margaret Cancer Centre, Toronto, Canada.
  • Lu S; Department of Shanghai Lung Cancer Center, Shanghai Jiao Tong University, Shanghai Chest Hospital, Shanghai, China.
  • de Marinis F; European Institute of Oncology, IRCCS, Milan, Italy.
  • Pérol M; Medical Oncology Department, Léon Bérard Cancer Center, Lyon, France.
  • Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Stiles BM; Albert Einstein College of Medicine, Montefiore Health System, Cardiothoracic and Vascular Surgery, New York, USA.
  • Tiseo M; University of Parma, Department of Medicine and Surgery and Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Tsuboi M; Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
ESMO Open ; 7(5): 100572, 2022 10.
Article em En | MEDLINE | ID: mdl-36108559

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Guideline / Qualitative_research Aspecto: Patient_preference Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Guideline / Qualitative_research Aspecto: Patient_preference Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido